Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Mark P. Callery

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5052135375. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 2 papers · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers

Papers 13

  1. Language Proficiency and Survival in Pancreatic Cancer: a Propensity Score-Matched Analysis. Co-author DOI 10.1007/s11605-021-05081-3↗
  2. Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-4116↗
  3. Is Margin Status Less Prognostic After Neoadjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma? First author DOI 10.1245/s10434-021-10885-3↗
  4. Biliary palliation for unresectable pancreatic adenocarcinoma: surgical bypass or self-expanding metal stent? Co-author DOI 10.1016/j.hpb.2019.08.014↗
  5. Is Neoadjuvant Therapy Sufficient in Resected Pancreatic Cancer Patients? A National Study. Co-author DOI 10.1007/s11605-017-3541-8↗
  6. Neoadjuvant therapy affects margins and margins affect all: perioperative and survival outcomes in resected pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2017.12.004↗
  7. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. Co-author DOI 10.1002/cncr.30856↗
  8. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis. Co-author DOI 10.1016/j.surg.2016.08.040↗
  9. A Tale of Two Cities: Reconsidering Adjuvant Radiation in Pancreatic Cancer Care. Co-author DOI 10.1007/s11605-015-2951-8↗
  10. Early surgical bypass versus endoscopic stent placement in pancreatic cancer. Co-author DOI 10.1016/j.hpb.2016.05.008↗
  11. Rankings versus reality in pancreatic cancer surgery: a real-world comparison. Co-author DOI 10.1111/hpb.12171↗
  12. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/j.1477-2574.2012.00571.x↗
  13. Conditional survival in pancreatic cancer: better than expected. Last author DOI 10.1111/j.1477-2574.2011.00379.x↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tara Sotsky Kent · 11 shared papers, 2011–2022 · strength 0.85
  2. Jennifer F. Tseng · 7 shared papers, 2014–2018 · strength 0.46
  3. Arthur James Moser · 6 shared papers, 2014–2020 · strength 0.44
  4. Susanna W.L. de Geus · 6 shared papers, 2016–2018 · strength 0.42
  5. Mariam F. Eskander · 5 shared papers, 2016–2018 · strength 0.34
  6. John Albert Windsor · 1 shared paper, 2022 · strength 0.33
  7. Gyulnara G. Kasumova · 4 shared papers, 2017–2018 · strength 0.31
  8. Mandeep Sawhney · 2 shared papers, 2020–2022 · strength 0.23
  9. Alexander L. Vahrmeijer · 3 shared papers, 2016–2018 · strength 0.22
  10. Lindsay A. Bliss · 3 shared papers, 2016–2017 · strength 0.19
  11. Alessandra Storino · 2 shared papers, 2016–2020 · strength 0.18
  12. Rodrigo Calvillo-Ortiz · 1 shared paper, 2022 · strength 0.16
  13. Anand Mahadevan · 2 shared papers, 2016–2017 · strength 0.12
  14. Kathryn A. Stackhouse · 1 shared paper, 2020 · strength 0.12
  15. Teviah Erik Sachs · 2 shared papers, 2011–2018 · strength 0.12
  16. Mary Linton B. Peters · 1 shared paper, 2022 · strength 0.11
  17. Raul S. González · 1 shared paper, 2022 · strength 0.11
  18. Andrea J. Bullock · 1 shared paper, 2022 · strength 0.11
  19. Ling Huang · 1 shared paper, 2022 · strength 0.11
  20. Joseph Elan Grossman · 1 shared paper, 2022 · strength 0.11
  21. Douglas K. Pleskow · 1 shared paper, 2022 · strength 0.11
  22. Manuel M. Hidalgo · 1 shared paper, 2022 · strength 0.11
  23. Leo L. Tsai · 1 shared paper, 2022 · strength 0.11
  24. Bruno Bockorny · 1 shared paper, 2022 · strength 0.11
  25. Senthil K. Muthuswamy · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.